RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $122

Benzinga Newsdesk www.benzinga.com Negative 84.3%

Neg 84.3% Neu 0% Pos 0%

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target from $123 to $122.